About GEMCITABIN E 2000MG/50M
Antimetabolite chemotherapy medicine
Used for
- Treats pancreatic, lung, breast, and ovarian cancers
- May be used alone or with other cancer medicines
Usual adult dose
Usually 800–1,250 mg/m² by intravenous infusion over 30 minutes, on schedules determined by cancer type and combination treatment.
Common side effects
- Low blood-cell counts and increased infection or bleeding risk
- Nausea, vomiting, or loss of appetite
- Fatigue, fever, or flu-like symptoms
- Liver-test changes, rash, or hair loss
Important warnings
- Can cause severe bone-marrow suppression; blood counts require monitoring.
- Seek urgent care for fever, unusual bleeding, breathing difficulty, or jaundice.
- Rarely causes serious lung injury, kidney failure, or severe skin reactions.
- Dosing and schedule must be managed by an oncology team.
Pregnancy
May harm an unborn baby. Avoid during pregnancy; effective contraception is recommended during treatment and for six months afterward.
Breastfeeding
Breastfeeding is not recommended during treatment and for at least one week after the final dose.
Interactions
- Radiotherapy may increase severe tissue and blood-related toxicity.
- Live vaccines may cause serious infection during chemotherapy.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.